This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (8)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Ahmad Fayaz, DVM; S. Simani; Shokrollah Nour-Salehi, DVM; Mahmoud Bahmanyar, DVM

JAMA. 1981;246(20):2334-2335.

Abstract
Contact was maintained with 27 of 45 persons for four years after their severe exposure to rabies virus and successful protection. During that time, these persons showed no adverse effects of treatment and maintained rabies-neutralizing antibody at the level of 2 to 91 IU/mL of serum. After a single booster inoculation of human diploid cell culture vaccine four years after the initial treatment, levels of neutralizing antibodies rose to 36 to 650 IU/mL of serum ten days after the booster inoculation. These observations confirm the persistence of rabies-specific serum antibodies for an extended (four years) period after vaccination. Furthermore, a single booster inoculation with human diploid cell culture vaccine resulted in a sharp increase in the level of antibodies, indicating that a person would probably be protected against a second exposure.

(JAMA 1981;246:2334-2335)

Author Affiliations
From the Institut Pasteur de l'Iran, World Health Organization Collaboration Center for Reference and Research in Rabies, Tehran, Iran.

Footnotes
Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Preexposure Immunization With Intradermal Human Diploid Cell Rabies Vaccine: Risks and Benefits of Primary and Booster Vaccination
Bernard et al.
JAMA 1987;257:1059-1063.
ABSTRACT